NPS PHARMACEUTICALS INC
DelistedCIK 890465fmd_0SNR0J2VTRB88X9FV1GKRAP2QTManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2009 to Dec 31, 2014, 20 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 |
|---|---|---|---|---|---|---|
| Total revenues | 84 | 89 | 102 | 131 | 156 | 224 |
| Cost of revenue | 0 | 0 | 0 | 0 | 4 | 15 |
| Gross profit | 84 | 89 | 102 | 131 | 152 | 209 |
| Realized investment gains (losses) | 1 | 4 | 0 | 0 | 0 | 0 |
| Research and development | 35 | 61 | 74 | 95 | 85 | 90 |
| Selling, general and administrative | – | – | 24 | 37 | 68 | 114 |
| Total operating expenses | 56 | 80 | 98 | 132 | 153 | 204 |
| Operating income | 28 | 10 | 1 | (1) | (1) | 5 |
| Interest expense | 53 | 45 | 38 | 18 | 12 | 14 |
| Interest and investment income | 2 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | (47) | (40) | (37) | (18) | (12) | (13) |
| Income before taxes | (20) | (30) | (36) | (19) | (13) | (8) |
| Income tax expense | (2) | 1 | 0 | 0 | 0 | 1 |
| Net income from continuing operations | (18) | (31) | (36) | (19) | (14) | (9) |
| Net income | (18) | (31) | (36) | (19) | (14) | (9) |